Our investors are especially pleased with the extraordinary reorder rates from existing customers, an indication of high customer satisfaction.
Pittsburgh, PA (PRWEB) May 3, 2010
Vinomis Laboratories, LLC, makers of the Resveratrol supplement, Vindure 900, announced today that it had successfully completed a new round of funding which will be used to expand the company’s marketing, advertising, and free trial programs. The entire round was taken up by current investors. The amount of the investment was not disclosed. Vinomis is a privately held company.
“Our investors have been very pleased with the rapid growth of the company,” noted Barry Yarkoni, CEO. “They are especially impressed with the extraordinary reorder rates from existing customers, an indication of high customer satisfaction.”
Vindure 900, Vinomis’ flagship product, is a high potency red wine based anti-aging supplement. Research at Harvard and other universities has shown that Resveratrol and other polyphenols found in red wine grapes can activate the SIRT genes, which has been shown in animal studies to play a key role in maintaining health and promoting longevity. Proprietary human studies on the ingredients in Vindure 900 have shown significant improvements in energy, endurance and memory. The company also has an exclusive patent license from Harvard Medical School.
During the past few years, a great deal of attention has been focused on Resveratrol, and it has been the focus of a number of news reports both in print and on television. Myriad stories have appeared on popular national television shows including 60 Minutes, Dr. Oz, Oprah, and Barbara Walters, focusing on research results involving Vindure 900 ingredients and their potential health benefits.
Vinomis Laboratories, LLC, is headquartered in Sewickley, PA. It was founded in 2009 by a group of physicians and business leaders dedicated to improving people's health and longevity.
# # #